Clinical Trial

Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy

Name: Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy — clinical trial record (NCT06302608)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated March 12, 2024 (before its estimated May 29, 2024 completion). Its status may not reflect the trial's current state.

Summary

Evaluate the safety and tolerability of NGGT001 subretinal injection for the treatment of crystalline retinal degeneration (BCD)

Trial Details

NCT Number	NCT06302608
Lead Sponsor	Xiamen Ophthalmology Center Affiliated to Xiamen University
Conditions	Bietti's Crystalline Dystrophy
Enrollment	6 participants
Start Date	2023-02-08
Primary Completion	2024-05-29 (estimated)
Study Completion	2028-05-29 (estimated)
Updated on ClinicalTrials.gov	2024-03-12